Drugmakers Side With Regeneron, Sanofi in Patent Case Over Amgen’s Repatha

Three drugmakers have filed amicus briefs in support of Regeneron and Sanofi’s efforts to reverse a district court ruling that validated Amgen patents on Repatha and barred the companies from selling their cholesterol drug Praluent.
Source: Drug Industry Daily